Financial statements Pharmsoft
Balance sheet data of PHARMSOFT
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 2 052 030,02 | 1 870 704,53 | 2 063 671,79 |
| A. Fixed assets | 275 241,68 | 1 387 815,71 | 1 981 536,44 |
| B. Current assets | 1 776 788,34 | 482 888,82 | 82 135,35 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 2 052 030,02 | 1 870 704,53 | 2 063 671,79 |
| A. Equity | 1 765 184,02 | 1 727 056,79 | 1 682 715,77 |
| B. Liabilities and provisions for liabilities | 286 846,00 | 143 647,74 | 380 956,02 |
| I. Long-term liabilities | 93 000,00 | 93 000,00 | 355 000,00 |
| II. Short-term liabilities | 193 846,00 | 50 647,74 | 25 956,02 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.